Microbix Biosystems (TSX:MBX) appointed Jim Currie as CFO, succeeding Charles Wallace, who is retiring at the end of the year.
Mr. Currie was most recently CFO of SMTC, a global electronics manufacturing services company. Previously, he was VP of finance at MDS SCIEX, a global leader in life science and analytical technologies.
In a statement, Vaughn Embro-Pantalony, president and CEO of Microbix, said Mr. Wallace was instrumental in helping the company improve its financial position in recent years. “And I welcome Jim to Microbix and to the leadership team. We look forward to working with him as we continue to focus on driving the growth of our company.”
